Arthrex Launches Patient Education Website for ACL Injuries

ACLTear.com to educate, connect patients suffering from common knee injuries with surgeons trained in innovative procedures

Arthrex, a global leader in minimally invasive orthopedic technology, launched a new patient-focused website, ACLTear.com, which illustrates the science of anterior cruciate ligament (ACL) injuries, highlights the benefits of knee preservation technology and provides tools to patients to connect with surgeons performing advanced, minimally invasive ACL procedures.

“As the innovation leader in arthroscopic surgery, Arthrex is defining the future for how ACL injuries are treated,” said Arthrex President and Founder Reinhold Schmieding. “ACLTear.com is a tremendous educational resource for patients who want comprehensive information based on extensive orthopedic research and real patient experiences.”

Arthrex recently released two solutions for minimally invasive ACL preservation: the ACL Repair TightRope® implant and the SwiveLock® ACL Repair Kit, the first of its kind in the orthopedic industry to gain FDA clearance. Unlike a reconstruction or complete replacement of the ACL, the new technology enabling the preservation of a patient’s own ACL may allow for an easier recovery1 with a more normal-feeling knee2 and a possible faster return to activity.3

“Arthrex is dedicated to helping patients gain a better understanding of their injuries and the techniques available to improve their outcomes,” said Senior Director of Product Management, Knee and Hip Arthroscopy Jake Jolly. “ACLTear.com is an educational hub for anyone suffering from an ACL injury to explore their treatment options and connect with expert surgeons nearby.”

Arthrex has been involved in developing ACL repair and reconstruction techniques since 1983, with the goal of creating less invasive procedures to assist patients in returning to activity more quickly. In developing these techniques, the company has thoroughly studied the procedures and associated clinical outcomes in high-impact peer-reviewed literature.1,4-6

ACL tears and sprains are among the most common sports injuries in the U.S., with an estimate of between 100,000 to 200,000 occurrences every year.7 Younger and sports-active patients are predominately affected, typically by twisting or hyperextension.

ACLTear.com offers an interactive Find a Doctor tool to help patients quickly and easily connect with surgeons in their area.

SourceArthrex,
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version